Literature DB >> 7440723

Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.

R L Sabina, J L Swain, B M Patten, T Ashizawa, W E O'Brien, E W Holmes.   

Abstract

A patient with symptoms of easy fatigability, postexercise myalgias, and delayed recovery of muscle strength after activity is described. Skeletal muscle from this patient had <1.0% normal myoadenylate deaminase activity and NH(3) was not released from muscle after ischemic exercise. In association with this enzyme deficiency, exercise led to a >90% reduction in muscle content of adenine nucleotides. No inosine monophosphate accumulated after exercise and total purine content of the muscle fell to 21% of control. Repletion of the adenine nucleotide pool in this patient was delayed compared to controls, and ATP content had only returned to 68% of control at 165 min after exercise. These studies demonstrate that disruption of the purine nucleotide cycle as a consequence of myoadenylate deaminase deficiency results in marked alterations in ATP content of muscle, and potentially, these changes in ATP content could account for muscle dysfunction in this patient.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7440723      PMCID: PMC371628          DOI: 10.1172/JCI109995

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  NUCLEOTIDES AND ADENOSINE MONOPHOSPHATE DEAMINASE ACTIVITY OF MUSCLE IN PRIMARY HYPOKALAEMIC PERIODIC PARALYSIS.

Authors:  A G ENGEL; C S POTTER; J W ROSEVEAR
Journal:  Nature       Date:  1964-05-16       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  NAD in muscle of man at rest and during exercise.

Authors:  T Graham; G Sjøgaard; H Löllgen; B Saltin
Journal:  Pflugers Arch       Date:  1978-08-25       Impact factor: 3.657

4.  Myoadenylate deaminase deficiency: a new disease of muscle.

Authors:  W N Fishbein; V W Armbrustmacher; J L Griffin
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

5.  Simultaneous analysis of ATP, ADP, AMP, and other purines in human erythrocytes by high-performance liquid chromatography.

Authors:  P D Schweinsberg; T L Loo
Journal:  J Chromatogr       Date:  1980-01-11

6.  Differential response of AMP deaminase isozymes to changes in the adenylate energy charge.

Authors:  C Solano; C J Coffee
Journal:  Biochem Biophys Res Commun       Date:  1978-11-29       Impact factor: 3.575

7.  Adenylate deaminase from rat muscle. Regulation by purine nucleotides and orthophosphate in the presence of 150 mM KCl.

Authors:  T J Wheeler; J M Lowenstein
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

8.  Purine metabolism during strenuous muscular exercise in man.

Authors:  J R Sutton; C J Toews; G R Ward; I H Fox
Journal:  Metabolism       Date:  1980-03       Impact factor: 8.694

9.  Myoadenylate deaminase deficiency.

Authors:  J B Shumate; R Katnik; M Ruiz; K Kaiser; C Frieden; M H Brooke; J E Carroll
Journal:  Muscle Nerve       Date:  1979 May-Jun       Impact factor: 3.217

  9 in total
  18 in total

1.  AMPD1 functional variants associated with autism in Han Chinese population.

Authors:  Lusi Zhang; Jianjun Ou; Xiaojuan Xu; Yu Peng; Hui Guo; Yongcheng Pan; Jingjing Chen; Tianyun Wang; Hao Peng; Qiong Liu; Di Tian; Qian Pan; Xiaobin Zou; Jingping Zhao; Zhengmao Hu; Kun Xia
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-26       Impact factor: 5.270

2.  Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.

Authors:  M A Tarnopolsky; G Parise; M J Gibala; T E Graham; J W Rush
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

3.  Deficiency of AMP deaminase in erythrocytes.

Authors:  N Ogasawara; H Goto; Y Yamada; I Nishigaki; T Itoh; I Hasegawa; K S Park
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

Review 4.  Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency.

Authors:  M Gross
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

5.  Increased ammonia production during forearm ischemic work test in McArdle's disease.

Authors:  K W Rumpf; H Wagner; H Kaiser; H M Meinck; H H Goebel; F Scheler
Journal:  Klin Wochenschr       Date:  1981-12-01

Review 6.  Myoadenylate deaminase deficiency.

Authors:  H H Goebel; A Bardosi
Journal:  Klin Wochenschr       Date:  1987-11-02

7.  Neonatal rotavirus infection.

Authors:  M Santosham; A Pathak; S Kottapalli; J Vergara; S J Wong; J Frochlick; R B Sack
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

8.  Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.

Authors:  R L Sabina; J L Swain; C W Olanow; W G Bradley; W N Fishbein; S DiMauro; E W Holmes
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

9.  Ergometer exercise in myoadenylate deaminase deficient patients.

Authors:  M Gross; U Gresser
Journal:  Clin Investig       Date:  1993-06

10.  Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.

Authors:  J L Swain; J J Hines; R L Sabina; O L Harbury; E W Holmes
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.